Project Details
| Short title | A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T) |
|---|---|
| Status | Active |
| Effective start/end date | 6/07/17 → 30/06/23 |
Funding
- PFIZER LIMITED
A Phase 2a trial of Avelumab, an anti-PDL 1 antibody, in relapsed and refractory peripheral T-cell lymphoma (AVAIL-T)
- Siddique, Shamyla (Co-Investigator)
- Jackson, Aimee (Co-Investigator)
- Craddock, Charles (Principal Investigator)